These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 7910494)

  • 1. Comparison of paclitaxel and docetaxel (Taxotere) in gynecologic and breast cancer cell lines with the ATP-cell viability assay.
    Untch M; Untch A; Sevin BU; Angioli R; Perras JP; Koechli O; Averette HE
    Anticancer Drugs; 1994 Feb; 5(1):24-30. PubMed ID: 7910494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Testing chemosensitivity of cancer cell lines and gynecologic tumors with the ATP assay].
    Untch M; Sevin BU; Untch A; Konecny G; Nestle-Krämling C; Korell M; Hepp H
    Gynakol Geburtshilfliche Rundsch; 1993; 33 Suppl 1():311-3. PubMed ID: 7906979
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
    Kelland LR; Abel G
    Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
    Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK
    Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 'Rings' of F-actin form around the nucleus in cultured human MCF7 adenocarcinoma cells upon exposure to both taxol and taxotere.
    Rosenblum MD; Shivers RR
    Comp Biochem Physiol C Toxicol Pharmacol; 2000 Jan; 125(1):121-31. PubMed ID: 11790336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
    Verweij J; Clavel M; Chevalier B
    Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of antitumour effects of docetaxel (Taxotere) on human gastric cancers in vitro and in vivo.
    Tanaka M; Obata T; Sasaki T
    Eur J Cancer; 1996 Feb; 32A(2):226-30. PubMed ID: 8664032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased response to paclitaxel versus docetaxel in HER-2/neu transfected human breast cancer cells.
    Witters LM; Santala SM; Engle L; Chinchilli V; Lipton A
    Am J Clin Oncol; 2003 Feb; 26(1):50-4. PubMed ID: 12576925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Taxane sensitivity of ovarian carcinoma in vitro.
    Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
    Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docetaxel in breast cancer and a rationale for combination therapy.
    Hortobágyi G
    Oncology (Williston Park); 1997 Jun; 11(6 Suppl 6):11-5. PubMed ID: 9213321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semi-synthesis of an O-glycosylated docetaxel analogue.
    Nikolakakis A; Haidara K; Sauriol F; Mamer O; Zamir LO
    Bioorg Med Chem; 2003 Apr; 11(7):1551-6. PubMed ID: 12628678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
    Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
    Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Taxotere resistance in SUIT Taxotere resistance in pancreatic carcinoma cell line SUIT 2 and its sublines.
    Liu B; Staren E; Iwamura T; Appert H; Howard J
    World J Gastroenterol; 2001 Dec; 7(6):855-9. PubMed ID: 11854916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative antitumor efficacy of docetaxel and paclitaxel in nude mice bearing human tumor xenografts that overexpress the multidrug resistance protein (MRP).
    Vanhoefer U; Cao S; Harstrick A; Seeber S; Rustum YM
    Ann Oncol; 1997 Dec; 8(12):1221-8. PubMed ID: 9496387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential impact of Raf-1 kinase activity on tumor cell resistance to paclitaxel and docetaxel.
    Britten RA; Klein K
    Anticancer Drugs; 2000 Jul; 11(6):439-43. PubMed ID: 11001384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
    Rangel C; Niell H; Miller A; Cox C
    Cancer Chemother Pharmacol; 1994; 33(6):460-4. PubMed ID: 7907952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of the microtubule-disturbing agents docetaxel (Taxotere), vinblastine and vincristine on epidermal growth factor-receptor binding of human breast cancer cell lines in vitro.
    Hanauske AR; Depenbrock H; Shirvani D; Rastetter J
    Eur J Cancer; 1994; 30A(11):1688-94. PubMed ID: 7833145
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro cytotoxicity of docetaxel in childhood acute leukemias.
    Consolini R; Pui CH; Behm FG; Raimondi SC; Campana D
    J Clin Oncol; 1998 Mar; 16(3):907-13. PubMed ID: 9508172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effect of anti-apoptotic genes Bcl-xL and c-FLIP on sensitivity of MCF-7 breast cancer cells to paclitaxel and docetaxel.
    Wang Z; Goulet R; Stanton KJ; Sadaria M; Nakshatri H
    Anticancer Res; 2005; 25(3c):2367-79. PubMed ID: 16080463
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of taxotere-related drug resistance in pancreatic carcinoma.
    Liu B; Staren ED; Iwamura T; Appert HE; Howard JM
    J Surg Res; 2001 Aug; 99(2):179-86. PubMed ID: 11469885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.